Effect of fluoxetine on brain oxidative stress, neuronal damage and behavioural induced in the olfactory bulbectomy model of depression

Letters in Drug Design and Discovery

Volumn 4, Issue 4, 2007, Pages 305-310

  Túnez, Isaac ^a   Medina, Francisco J ^a   Jimena, Ignacio ^a   Muñoz, María Del C ^a   Peña, José ^a   Tasset, Inmaculada ^a   Montilla, Pedro ^a  

^a Universidad de Cordoba   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; FLUOXETINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ENZYME ACTIVITY; FORCED SWIMMING TEST; LIPID PEROXIDATION; MALE; NERVE CELL LESION; NONHUMAN; OLFACTORY BULBECTOMY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 34248190041     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018007784620013     Document Type: Article

References (26)

1. Nowak, G.; Szewczyk, B.; Wieronska, J.M.; Branski, P.; Palucha, A.; Pils, A.; Sadlik, K.; Piekoszewski, W. Brain Res. Bul., 2003, 61, 159.
2. Akiskal, H.S. J. Affect Disord., 2005, 84, 279.
3. Papakostas, G.I.; Petersen, T.; Mahal, Y.; Mischoulon, D.; Nierenberg, A.A.; Fava, M. Gen. Hosp. Psychiatry, 2004, 26, 13.
4. Shelton, R.C. J. Clin. Psyciatry, 2004, 65, 5.
5. Baumann, P. Clin. Pharmacokinet., 1996, 31, 444.
6. Weilburg, J.B.; Rosenbaum, J.F.; Biederman, J.; Sachs, G.S.; Pollack, M.H.; Kelly, K. J. Clin. Psychiatry, 1989, 50, 447.
7. Seth, R.; Jennings, A.L.; Bidman, J.; Philips, J.; Bergmann, K. Br. J. Psychiatry, 1992, 161, 562.
8. Khanzode, S.D.; Dakhale, G.N.; Khanzode, S.S.; Saoji, A.; Palasodkar, R. Redox Rep., 2003, 8, 365.
9. Forlenza, M.J.; Miller, G.E. Psychosom. Med., 2006, 68, 1.
10. Song, C.; Leonard, B.E. Neurosci. Biobehav. Rev., 2005, 29, 627.
11. Nowak, G.; Szewczyk, B.; Wieronska, J.M.; Branski, P.; Palucha, A.; Pilc, A.; Sadlik, K.; Wojciech, P. Brain Res. Bull., 2003, 61, 159.
12. Flohé, L.; Gunzler, W.A. Methods Enzymol., 1984, 105, 114.
13. Xu, Y.; Ku, B.S.; Yao, H.Y.; Lin, Y.H.; Ma, X.; Zhang, .H.; Li, X.J. Pharmacol. Biochem. Behav., 2005, 82, 200.
14. Porsolt, R.D.; Anton, G.; Blavet, N.; Jalfre, M. Eur. J. Pharmacol., 1978, 47, 379.
15. Forlenza, M.J.; Miller, G.E. Psychosom. Med., 2006, 68, 1.
16. Herken, H.; Akyol, O.; Yilmaz, H.R.; Tutkun, H.; Savas, H.A.; Ozen, M.E.; Kalenderogly, A.; Gulec, M. Hum. Psychopharmacol., 2006, 21, 53.
17. Forlenza, M.J.; Miller, G.E. Psychosom. Med., 2006, 68, 1.
18. icholson, D.W.; Ali, A.; Thornberry, N.A.; Vaillancourt, J.P.; Ding, C.K.; Gallant, M.; Gareau, Y.; Griffin, P.R.; Labelle, M.; Lazebnik, Y.A.; Munday, N.A.; Raju, S.M.; Smulson, M.E.; Yamin, T.T.; Yu, V.L.; Miller, D.K. Nature, 1995, 376, 37.
19. Jaako-Movits, K.; Zharkovsky, A. Eur. J. Neurosci., 2005, 22, 2871.
20. Robinson, A.M.; Conley, D.B.; Kern, R.C. Neuroreport., 2003, 14, 1891.
21. Mar, A.; Spreekmeester, E.; Rochford, J. Psychopharmacology, 2000, 150, 52.
22. Rénéric, J.P.; Lucki, I. Psychopharmacology, 1998, 136, 190.
23. Alberts, J.R.; Friedman, M.I. Nature, 1972, 238, 454.
24. Masini, C.V.; Holmes, P.V.; Freeman, K.G.; Maki, A.C.; Edwards, G.L. Physiol. Behav., 2004, 81, 111.
25. Hellweg, R.; Zueger, M.; Fink, K.; Hörtnagl, H.; Gass, P. Neurobiol. Dis., 2007, 25, 1.
26. van der Stelt, H.M.; Breuer, M.E.; Olivier, B.; Westenberg, H.G. Biol. Psychiatry, 2005, 57, 1061.